91Ó°ÊÓ

Refer to a clinical trial named APPROVe designed to determine whether Vioxx, a medication used for \(a r\) thritis and acute pain, was effective in preventing the recurrence of colorectal polyps in patients with a history of colorectal adenomas. APPROVe was conducted between 2002 and 2003 and involved 2586 participants, all of whom had a history of colorectal adenomas. The participants were randomly divided into two groups: 1287 were given 25 milligrams of Vioxx daily for the duration of the clinical trial (originally intended to last three years), and 1299 patients were given a placebo. Neither the participants nor the doctors involved in the clinical trial knew who was in which group. During the trial, 72 of the participants had cardiovascular events (mostly heart attacks or strokes). Later it was found that 46 of these people were from the group taking the Vioxx and only 26 were from the group taking the placebo. Based on these results, the clinical trial was stopped in 2003 and Vioxx was taken off the market in 2004. Describe the sample for APPROVe.

Step by step solution

01

Identify the sample in the text

The text mentions that 2586 participants were involved in the APPROVe clinical trial. All these participants had a history of colorectal adenomas.

02

Identify the composition of the sample

The participants were divided into two groups: 1287 were given 25 milligrams of Vioxx daily, and 1299 patients were given a placebo.

03

Noting additional information researchers had about the sample

72 participants had cardiovascular events during the trial, of these, 46 were from the group taking Vioxx, and 26 were from the placebo group.

Unlock Step-by-Step Solutions & Ace Your Exams!

• Full Textbook Solutions

  Get detailed explanations and key concepts

• Unlimited Al creation

  Al flashcards, explanations, exams and more...

• Ads-free access

  To over 500 millions flashcards

• Money-back guarantee

  We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91Ó°ÊÓ!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

Sample Composition

In clinical trials, the composition of your sample population is crucial to ensure your study is valid and relevant. In the APPROVe trial, the sample consisted of 2586 participants who all had a history of colorectal adenomas.
This specific history was a key eligibility criterion as the trial aimed to assess the effectiveness of Vioxx in preventing colorectal polyps' recurrence. Here, the characteristics of a well-defined sample include:

• Specific Background: All participants previously had colorectal adenomas, focusing the study on a group that would benefit most from the treatment being tested.
• Random Assignment: The sample was randomly split into two groups ensuring unbiased distribution of participants.

Sample composition impacts the ability to generalize the study results to a broader population. By carefully selecting participants, researchers hoped the trial would provide insights relevant to patients with similar histories.

Randomized Controlled Trial

Randomized controlled trials (RCTs) form the gold standard in clinical research to assess the efficacy or safety of treatments. In an RCT, participants are randomly assigned to different groups to reduce the risk of bias. This is exactly what was done in the APPROVe trial.
Participants were split into two groups:

• Treatment Group: 1287 received Vioxx, a medication under investigation.
• Control Group: 1299 were given a placebo, serving as a comparison measure.

By using randomization, researchers helped ensure both known and unknown factors were evenly distributed across the groups. This helps in conclusively attributing any differences in outcomes, like cardiovascular events in this case, directly to the treatment rather than external variances. Thus, the randomization in the APPROVe trial was essential to establishing a clear cause-and-effect relationship between Vioxx usage and its health impacts.

Double-Blind Study

In a double-blind study, neither the participants nor the experimenters know who receives the treatment versus the placebo during the trial. In the APPROVe clinical trial, this method was meticulously applied.
Double-blinding helps eliminate bias in the results by:

• Preventing Participant Bias: Participants may subconsciously report differently if they know which group they're in.
• Preventing Researcher Bias: Researchers could unconsciously skew results if aware of who receives what treatment.

By maintaining blindness for both participants and researchers, the trial aimed to objectively assess the efficacy of Vioxx. Such methodology is particularly important in trials, like APPROVe, where subjective outcomes (e.g., symptomatic differences) could influence the study. Consequently, this rigorous setup helps maintain the integrity of the data collected throughout the trial.